Difference between revisions of "OncoMouse"
From Cyborg Anthropology
Caseorganic (Talk | contribs) |
Caseorganic (Talk | contribs) |
||
| Line 3: | Line 3: | ||
OncoMouse was also the first patented animal. Two patents were awarded to Harvard College describing methods for "providing a cell culture from a transgenic non-human animal".<ref>U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.</ref> | OncoMouse was also the first patented animal. Two patents were awarded to Harvard College describing methods for "providing a cell culture from a transgenic non-human animal".<ref>U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.</ref> | ||
| + | |||
| + | |||
==References== | ==References== | ||
| Line 8: | Line 10: | ||
[[Category:Book Pages]] | [[Category:Book Pages]] | ||
| − | [[Category: | + | [[Category:Unfinished]] |
Revision as of 02:29, 26 March 2012
Definition
OncoMouse is both a noun and a trademark. OncoMouse describes a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.[1] Philip Leder and Timothy A Stewart[2] of Harvard University designed the mouse to carry an activated oncogene, a gene that in certain circumstances can transform a cell into a tumor cell. This makes suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.[3]
OncoMouse was also the first patented animal. Two patents were awarded to Harvard College describing methods for "providing a cell culture from a transgenic non-human animal".[4]
References
- ↑ New Oxford American Dictionary. 2011.
- ↑ European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.
- ↑ Trademark: USPTO serial number 75797027
- ↑ U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.
